Latest & greatest articles for endometriosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on endometriosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on endometriosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for endometriosis

21. Combination of the non-invasive tests for the diagnosis of endometriosis.

Combination of the non-invasive tests for the diagnosis of endometriosis. BACKGROUND: About 10% of women of reproductive age suffer from endometriosis, a costly chronic disease causing pelvic pain and subfertility. Laparoscopy is the gold standard diagnostic test for endometriosis, but is expensive and carries surgical risks. Currently, there are no non-invasive tests available in clinical practice to accurately diagnose endometriosis. This review assessed the diagnostic accuracy (...) of combinations of different non-invasive testing modalities for endometriosis and provided a summary of all the reviews in the non-invasive tests for endometriosis series. OBJECTIVES: To estimate the diagnostic accuracy of any combination of non-invasive tests for the diagnosis of pelvic endometriosis (peritoneal and/or ovarian or deep infiltrating) compared to surgical diagnosis as a reference standard. The combined tests were evaluated as replacement tests for diagnostic surgery and triage tests to assist

Cochrane2016

22. Intussusception of the Appendix and Ileum Endometriosis: A Case Report

Intussusception of the Appendix and Ileum Endometriosis: A Case Report 27493950 2016 08 05 2018 11 13 2297-4725 32 3 2016 Jun Visceral medicine Visc Med Intussusception of the Appendix and Ileum Endometriosis: A Case Report. 211-3 10.1159/000445394 Intussusception of the appendix is a very rare condition. It may clinically mimic acute or chronic abdominal diseases or can be asymptomatic. This paper describes our experience with intussusception of the appendix. We report a case of a female (...) with appendiceal intussusception and ileum endometriosis. It is important to know about such a rare condition in order to avoid mistaking it with other abdominal diseases. However, diagnosis is rarely made preoperatively. Dainius Edvinas E Department of Surgery, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania, Kaunas, Lithuania; Department of Surgery, Kaunas Clinical Hospital, Kaunas, Lithuania. Pankratjevaite Lina L Department of Surgery, Medical Academy, Lithuanian University

Visceral medicine2016 Full Text: Link to full Text with Trip Pro

23. Pregnancy outcomes in women with endometriosis: a national record linkage study

Pregnancy outcomes in women with endometriosis: a national record linkage study 26887349 2016 02 18 2017 02 20 1471-0528 124 3 2017 Feb BJOG : an international journal of obstetrics and gynaecology BJOG Pregnancy outcomes in women with endometriosis: a national record linkage study. 444-452 10.1111/1471-0528.13920 To determine pregnancy outcomes in women with endometriosis. A national population based cohort study using record linkage. Scotland. A cohort of 14 655 women followed up over a 30 (...) -year period (1981-2010). In a nationwide Scottish study, we compared pregnancy outcomes in 5375 women with surgically confirmed endometriosis with outcomes in 8710 women without endometriosis who were pregnant during the same time period. Data were analysed using univariable and multivariable logistic regression after adjusting for confounding factors. Outcome measures evaluated included miscarriage, ectopic pregnancy, stillbirths and other pregnancy complications such as hypertensive disorders of

EvidenceUpdates2016

24. Urinary biomarkers for the non-invasive diagnosis of endometriosis.

Urinary biomarkers for the non-invasive diagnosis of endometriosis. BACKGROUND: About 10% of reproductive-aged women suffer from endometriosis which is a costly chronic disease that causes pelvic pain and subfertility. Laparoscopy is the 'gold standard' diagnostic test for endometriosis, but it is expensive and carries surgical risks. Currently, there are no simple non-invasive or minimally-invasive tests available in clinical practice that accurately diagnoses endometriosis. OBJECTIVES: 1 (...) . To provide summary estimates of the diagnostic accuracy of urinary biomarkers for the diagnosis of pelvic endometriosis compared to surgical diagnosis as a reference standard.2. To assess the diagnostic utility of biomarkers that could differentiate ovarian endometrioma from other ovarian masses.Urinary biomarkers were evaluated as replacement tests for surgical diagnosis and as triage tests to inform decisions to undertake surgery for endometriosis. SEARCH METHODS: The searches were not restricted

Cochrane2015

26. Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial

Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial 25694383 2015 07 07 2016 03 31 2015 07 07 1552-4604 55 8 2015 Aug Journal of clinical pharmacology J Clin Pharmacol Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial. 848-53 10.1002/jcph.485 Seventy patients with stage III or IV endometriosis were randomly assigned to 2 groups after conservative surgery (...) ), and bone mineral density (BMD) scores were recorded. The incidence of uterine bleeding was assessed. In both groups, serum levels of E2 , FSH, and LH and VAS scores decreased significantly after treatment. Spotting was the most frequent bleeding pattern. During cycle 1, the bleeding time in group M was much longer that than that in group O (P =.001), and the bleeding rate in group M was significantly higher than that in group O (P =.024, RR = 1.185). In patients with stage III or IV endometriosis, the efficacy of GnRH

EvidenceUpdates2015

27. Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe?

Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe? Hormone Therapy for the Menopause after Endometriosis Surgery - Friend or Foe? - Evidently Cochrane Search and hit Go By March 12, 2015 // In today’s guest blog, Dr Martin Hirsch explains about endometriosis and treatment choices for women who have the menopause induced because of it. It’s Menopause Week here at Evidently Cochrane and as a team including individual bloggers, Cochrane UK, Healthtalk and Menopause UK (...) with their NHS Change Day campaign to ‘Change the Change’, we are summarising the evidence surrounding the menopause to ensure women get the correct facts from reliable evidence. This blog aims to help women who have had the menopause induced through surgery for endometriosis make more informed health decisions at a time of significant change for their mind and body. Endometriosis – what is it and how do I know if I have it? Most women have heard of the menopause. They fear it, but for a select few

Evidently Cochrane2015

28. Interventions effective for endometriosis

Interventions effective for endometriosis Interventions effective for endometriosis | Cochrane Primary Care Top menu Trusted evidence. Informed decisions. Better health. Enter terms Interventions effective for endometriosis Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2017 The Cochrane Collaboration | |

Cochrane PEARLS2014

29. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by If you’re a woman living with endometriosis, the chances are you’ll be coping with chronic pain, and you may be facing fertility problems too. Here we look at a new overview of Cochrane systematic reviews, which brings together the best available evidence on treatments for these two devastating aspects (...) of endometriosis. Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments

Evidently Cochrane2014

30. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility - Evidently Cochrane Search and hit Go By March 20, 2014 // Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment (...) is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments, with or without surgery. For women with fertility problems associated with endometriosis, drug treatments, surgery and assisted reproductive technologies (ART) may all be considered. Overviews can really help if you are making decisions about treatments, as they bring together in one place the best evidence we have, summarising systematic reviews

Evidently Cochrane2014

31. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by If you’re a woman living with endometriosis, the chances are you’ll be coping with chronic pain, and you may be facing fertility problems too. Here we look at a new overview of Cochrane systematic reviews, which brings together the best available evidence on treatments for these two devastating aspects (...) of endometriosis. Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments

Evidently Cochrane2014

32. Endometriosis: an overview of Cochrane Reviews.

Endometriosis: an overview of Cochrane Reviews. BACKGROUND: This overview reports on interventions for pain relief and for subfertility in pre-menopausal women with clinically diagnosed endometriosis. OBJECTIVES: The objective of this overview was to summarise the evidence from Cochrane systematic reviews on treatment options for women with pain or subfertility associated with endometriosis. METHODS: Published Cochrane systematic reviews reporting pain or fertility outcomes in women (...) with clinically diagnosed endometriosis were eligible for inclusion in the overview. We also identified Cochrane reviews in preparation (protocols and titles) for future inclusion. The reviews, protocols and titles were identified by searching the Cochrane Database of Systematic Reviews and Archie (the Cochrane information management system) in March 2014.Pain-related outcomes of the overview were pain relief, clinical improvement or resolution and pain recurrence. Fertility-related outcomes were live birth

Cochrane2014

33. Endometriosis

Endometriosis Endometriosis - NICE CKS Clinical Knowledge Summaries Share Endometriosis - Summary Endometriosis is the presence of tissue resembling endometrial glands and stroma outside the uterine cavity, which induces a chronic inflammatory reaction. It is often associated with dysmenorrhoea, pelvic pain, and subfertility. Most deposits occur in the pelvis, and this ectopic tissue is oestrogen-dependent and responds to the hormonal changes of the menstrual cycle. If the ovaries are affected (...) , ovarian cysts (endometriomas) may develop. Subfertility may be due to distortion of pelvic anatomy due to adhesions or endometriomas, or disturbance of reproductive processes. Endometriosis is most commonly diagnosed in women between 30 and 40 years of age, and is uncommon in those younger than 20 years of age. The following signs and symptoms may indicate the presence of endometriosis. Symptoms typically start after several years of painless periods. Cyclical or chronic pelvic pain, usually before

NICE Clinical Knowledge Summaries2014

35. Caesarean section and risk for endometriosis: a prospective cohort study of Swedish registries

Caesarean section and risk for endometriosis: a prospective cohort study of Swedish registries 23663181 2013 07 10 2013 09 17 2013 07 10 1471-0528 120 9 2013 Aug BJOG : an international journal of obstetrics and gynaecology BJOG Caesarean section and risk for endometriosis: a prospective cohort study of Swedish registries. 1061-5 10.1111/1471-0528.12236 To investigate the association between caesarean section and later endometriosis. A prospective cohort study. The Swedish Patient Register (PAR (...) ) and the Swedish Medical Birth Registry (MBR). Women who were delivered in Sweden between 1986 and 2004. Women with the diagnosis of endometriosis, defined as codes 617 (International Classification of Diseases, ninth revision, ICD-9) or N80 (ICD-10), were retrieved from the PAR. Obstetric outcome was assessed through linkage with the MBR. Out of 709,090 women, 3110 were treated as inpatients with a first diagnosis of endometriosis after their first delivery. Women with a diagnosis of endometriosis before

EvidenceUpdates2013

36. Laparoscopic CO2 laser ablation for endometriosis

Laparoscopic CO2 laser ablation for endometriosis Laparoscopic CO2 laser ablation for endometriosis Laparoscopic CO2 laser ablation for endometriosis Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Laparoscopic CO2 laser ablation for endometriosis. Lansdale: HAYES, Inc.. Directory Publication. 2013 Authors' conclusions Laparoscopic carbon dioxide (CO2) laser (...) ablation (LCLA) is a nearly bloodless surgical procedure designed to vaporize abnormal tissues, including endometriotic lesions, with minimal damage to surrounding normal tissue. The most common purpose of LCLA in endometriosis is to restore fertility and/or relieve associated pelvic pain. The LCLA technique can be part of a diagnostic and therapeutic procedure. If employed to restore fertility, LCLA enables attempts at conception right after surgery without the typical several months of delay required

Health Technology Assessment (HTA) Database.2013

37. Anti-TNF-α treatment for pelvic pain associated with endometriosis.

Anti-TNF-α treatment for pelvic pain associated with endometriosis. BACKGROUND: Endometriosis is a chronic, recurring condition that can develop during the reproductive years. It is characterised by the development of endometrial tissue outside the uterine cavity. It is the most common cause of pelvic pain in women. This endometrial tissue development is dependent on oestrogen produced primarily by the ovaries and, therefore, traditional management has focused on suppression of ovarian function (...) . Mounting evidence shows that altered immune function plays a crucial role in the genesis and development of endometriosis. In this review we considered modulation of the inflammation as an alternative approach. OBJECTIVES: To determine the effectiveness and safety of anti-tumour necrosis factor-α (anti-TNF-α) treatment in the management of endometriosis in premenopausal women. SEARCH METHODS: For the first publication of this review, we searched for trials in the following databases (from

Cochrane2013

40. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial

Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial 22314873 2012 02 23 2012 04 18 2013 11 21 1873-233X 119 3 2012 Mar Obstetrics and gynecology Obstet Gynecol Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. 519-26 10.1097/AOG.0b013e31824264c3 To estimate the effectiveness of a postoperative levonorgestrel-releasing intrauterine system (...) for relieving pelvic pain in patients with endometriosis. A double-blind randomized controlled trial was conducted in 55 patients with endometriosis and moderate-to-severe dysmenorrhea (visual analog scale, greater than 50 mm) undergoing laparoscopic conservative surgery. After surgery, patients were randomized to a levonorgestrel-releasing intrauterine system (n=28) or expectant management (n=27) group. Primary outcome was the change of dysmenorrhea visual analog scale. Secondary outcomes included changes

EvidenceUpdates2012